Najnowsze wersje próbne

EudraCT Number: 2004-003764-30

Sponsor Protocol Number: D/P2/04/3

Start Date: 2004-12-13

Sponsor Name: Diamyd Therapeutics AB

Full Title: A Phase II, Randomised, Double-Blind, Placebo-controlled, Multi-centre Study to Investigate the Impact of Diamyd on the Progression of diabetes in Patients Newly Diagnosed with Type 1 Diabetes Mell...

Medical condition: Type 1 diabetes

Disease:	Version	SOC Term	Classification Code	Term	Level
	9.1		10045228	Type I diabetes mellitus	LLT

Population Age: Children, Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: SE (Completed)

Trial results: (No results available)

EudraCT Number: 2004-004083-77

Sponsor Protocol Number: NO 002 CS 001

Start Date: 2004-12-13

Sponsor Name: Disphar International B.V.

Full Title: A Randomised, International, Multicenter Study to assess the Efficacy and Safety of Mesalazine EC tablets 500 mg (4.5g/daily) and Salofalk® tablets 500 mg (4.5 g/daily) in the Treatment of Moderate...

Medical condition: Moderate active Crohn disease

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: CZ (Completed) SK (Completed)

Trial results: (No results available)

EudraCT Number: 2004-000623-16

Sponsor Protocol Number: 1100.1454

Start Date: 2004-12-13

Sponsor Name: Boehringer Ingelheim Ltd

Full Title: A retrospective study to compare the 3-year antiviral efficacy of nevirapine and efavirenz in combination with D4T and 3TC in 2NN patients

Medical condition: Treatment of HIV-1 infection

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adolescents, Under 18, Adults

Gender: Male, Female

Trial protocol: GB (Completed) BE (Completed)

Trial results: View results

EudraCT Number: 2004-002276-42

Sponsor Protocol Number: 61/O4/OX/Rh

Start Date: 2004-12-13

Sponsor Name: IVAX Pharmaceuticals s.r.o.

Full Title: Tolerability and safety of Oxamet® in patients with acute rhinitis

Medical condition: Acute rhinitis.

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults

Gender: Male, Female

Trial protocol: CZ (Completed)

Trial results: (No results available)

EudraCT Number: 2004-003238-32

Sponsor Protocol Number: v1

Start Date: 2004-12-13

Sponsor Name: Dept. of Clinical Pharmacology

Full Title: Effect of pioglitazone on portal and systemic hemodynamics in patients with advanced cirrhosis

Medical condition: Cirrhosis of the liver

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: AT (Completed)

Trial results: (No results available)

EudraCT Number: 2004-001989-41

Sponsor Protocol Number: 26866138-MMY-3002

Start Date: 2004-12-13

Sponsor Name: Janssen-Cilag Kft.

Full Title: An Open-Label, Randomized Study of VELCADE/Melphalan/Prednisone versus Melphalan/Prednisone in subjects with previously untreated Multiple Myeloma.

Medical condition: First-Line Multiple Myeloma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: HU (Completed) FI (Completed) AT (Completed) CZ (Completed) IE (Completed) GB (Completed) DE (Completed) BE (Completed) ES (Ongoing) IT (Completed)

Trial results: View results

EudraCT Number: 2004-002985-39

Sponsor Protocol Number: ML18253

Start Date: 2004-12-13

Sponsor Name: ROCHE

Full Title: A multicenter, randomized, controlled study comparing the efficacy and safety of 48 weeks of 40kD branched pegylated interferon alfa-2a (PEGASYS, Ro 25-8310) versus 96 weeks of PEGASYS, alone or in...

Medical condition: Treatment of chronic hepatitis B, HBeAg-negative

Disease:	Version	SOC Term	Classification Code	Term	Level
	14.1	10021881 - Infections and infestations	10019731	Hepatitis B	PT

Population Age: Adults

Gender: Male, Female

Trial protocol: IT (Completed)

Trial results: View results

EudraCT Number: 2004-001953-27

Sponsor Protocol Number: 9321

Start Date: 2004-12-13

Sponsor Name: University Hospitals of Leicester NHS Trust

Full Title: The Pharmacokinetics of Systemic Corticosteriods in Refractory Asthma

Medical condition: Severe, refractory asthma

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Adults, Elderly

Gender: Male, Female

Trial protocol: GB (Completed)

Trial results: View results

EudraCT Number: 2004-001861-17

Sponsor Protocol Number:

Start Date: 2004-12-12

Sponsor Name: NOPHO-NHL GRUPP

Full Title: EURO-LB-02. Treatment Protocol for Lymphoblastic Lymphoma of the European Inter-group Co-operation on Childhood Non-Hodgkin-Lymphoma (EICNHL).

Medical condition: Multicenter randomised trial conducted in european countries and the five nordic countries on children up to the age of 18 years newly diagnosed with T-cell and and pre -B lymphoblastic lymphoma (T...

Disease:

Version

SOC Term

Classification Code

Term

Level

Population Age: Children, Adolescents, Under 18

Gender: Male, Female

Trial protocol: SE (Temporarily Halted) NO (Prematurely Ended) IT (Prematurely Ended) DK (Prematurely Ended)

Trial results: (No results available)

EudraCT Number: 2004-004150-51

Sponsor Protocol Number: A3871029

Start Date: 2004-12-10

Sponsor Name: Pfizer Limited

Full Title: A Phase 2 multi centre, double blind, placebo controlled flexible dose study to assess the efficacy and safety of oral UK-390,957 in men with premature ejaculation.

Medical condition: Premature Ejaculation

Disease:	Version	SOC Term	Classification Code	Term	Level
	7.0		10036596		LLT

Population Age: Adults, Elderly

Gender: Male

Trial protocol: GB (Completed)

Trial results: View results

Najnowsze wersje próbne

Sponsorzy i współpracownicy

Warunki medyczne

Interwencje lekowe